BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  FDA

  FDA Slaps Down Verrica’s Skin Disease Treatment Over Quality Concerns at CMO

  The FDA did not identify any deficiencies related to the manufacturing of the asset. However, the agency did identify deficiencies at the facility of a CMO Verrica is working with.

  September 21, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Cabometyx Proves its Worth in Phase III Differentiated Thyroid Cancer Study

  The Phase III COSMIC-311 trial for CABOMETYX delivered favorable final results in terms of objective response rate, progression-free survival, median overall survival, and safety.

  September 21, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  COVID-19 Death Toll Surpasses 1918 Spanish Flu

  In September 20, 2021, the United States marked a grisly milestone, recording more American deaths from COVID-19 than died from the 1918-1919 Spanish flu pandemic.

  September 21, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Deals

  Novartis Adds to Optogenetics Portfolio with Arctos Medical Buy

  Novartis expands its optogenetics portfolio with the acquisition of Arctos Medical, cementing its commitment to optogenetics-based therapies to restore vision to patients with advanced blindness.

  September 21, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  COVID-19 Updates: Vaccines for Children, Data on Efficacy and More

  As the COVID-19 pandemic hit a grim milestone, marking more U.S. deaths than were reported in the 1918–19 Spanish flu pandemic, research and breakthroughs continue.

  September 21, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Nektar Therapeutics Pairs NKTR-255 with Bavencio in Bladder Cancer Study

  Nektar collaborates with Pfizer and Merck KGaA, Darmstadt, Germany, to assess NKTR-255 in combination with Bavencio in patients with bladder cancer.

  September 21, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  San Diego Biotech Uncloaks with $60 Million to Tackle Treatment-Resistant Cancers

  On Tuesday, 858 Therapeutics launched with a $60 million Series A financing round under its belt.

  September 21, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Heart Failure Patients Take Heart as Carmat’s Bioprosthetic Implanted into First Woman

  French artificial heart maker Carmat announced Tuesday that it had successfully implanted its Aeson artificial heart into the chest cavity of a 57-year-old woman.

  September 21, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  BioMidwest

  Money on the Move: September 15 – 21

  The investor trees are dropping their leaves. Here’s who’s benefiting this week in the life sciences industry.

  September 21, 2021

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Breakthrough Cervical Cancer Treatment Wins Accelerated FDA Approval

  It earned the FDA’s green light after its Phase II innovaTV 204 clinical trial delivered stellar results in terms of tumor response and durability of the response.

  September 21, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN